Search results
Risk Stratification in Arrhythmogenic Mitral Valve Prolapse
Added:
1 year ago
Review Article
Added:
1 month ago
EHRA 2026 — Dr Jason Andrade (University of British Columbia, CA) joins us to explore how artificial intelligence is transforming risk prediction and modulation in arrhythmia management, and what this means for electrophysiology practice today and in the years ahead.From the limitations of conventional risk stratification tools to the emerging role of AI-driven models in clinical decision-making,…
View more
Overview of Genetic Risk Factors and Aetiologies
Added:
9 months ago
Review Article
Added:
2 weeks ago
Dr Usha Tedrow (Brigham and Women's Hospital, Boston, MA, US) discusses contemporary approaches to VT ablation in patients with complex and high-risk substrates, from preprocedural planning and mapping strategy through to long-term management.Interview Questions:How has the approach to VT ablation in high-risk substrates evolved over recent years, and what factors define a patient as high-risk…
View more
Added:
1 month ago
EHRA Congress 2026 — Dr Francesco Santoro (University of Foggia, Foggia, IT) joins us to explore how electrophysiologists can approach risk assessment and decision-making when considering catheter ablation in high-risk ventricular tachycardia patients — a population where the potential benefits of ablation must be carefully weighed against procedural complexity and patient frailty.Interview…
View more
Added:
1 month ago
HRS 2026 – Dr Enrico Ferro (Beth Israel Deaconess Medical Center, Boston, MA) returns to discuss findings from a large single-centre comparative safety analysis of pulsed field ablation (PFA) versus radiofrequency (RF) ablation for atrial fibrillation, originally presented at EHRA 2026 in Paris as a Young Investigator Award submission.Conducted at one of the highest-volume PVI centres in the US,…
View more
Added:
8 months ago
Source:
Radcliffe Cardiology
AUTHOR: Jordan RanceRisk stratification for primary prevention implantable cardioverter-defibrillator (ICD) placement in patients with cardiac sarcoidosis remains a clinical challenge, partly due to inconsistencies in diagnostic criteria and the variable course of the disease. A new study published in the European Heart Journal suggests that cardiovascular magnetic resonance (CMR) phenotyping has…
View more
Added:
1 month ago
HRS Congress 2026 — Dr Kenneth Bilchick (UVA Heart & Vascular Center, Charlottesville, VA, US) joins us to discuss findings from a study examining whether the protective effect of glucagon-like peptide-1 (GLP-1) receptor agonists on atrial fibrillation risk operates independently of weight loss and survival.Interview Questions:What is the current understanding of how GLP-1 receptor agonists may…
View more
Aortic Atherosclerosis as a Predictor of LAA Thrombus
Added:
9 months ago
Original Research
Added:
9 months ago
Source:
Arrhythmia Academy
Complete heart block (CHB) is a life-threatening arrhythmia, yet current electrocardiography (ECG)-based methods for risk stratification have limited predictive power. A new study has detailed the development and validation of a novel artificial intelligence-enhanced ECG (AI-ECG) model that can accurately predict the risk of incident CHB, significantly outperforming traditional risk markers.¹The…
View more